Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Indigenous Bloom Hemp Corp
VRTHF
Healthcare
Biotechnology
Cannabis
Indigenous Bloom Hemp Corporation is a Canada-based company, which produce and sell hemp extracts. The Company operates a large scale industrial hemp farm in southern Manitoba on approximately 200 acres of zoned farmland. The primary business of the Company is the sale of hemp biomass and flower (Hemp), Phyto cannabinoid rich (PCR) extracts derived from hemp biomass (Hemp Extracts). The Company...
is in the process of developing, through acquisition and construction, Hemp Products for general consumer end-use. It has two primary products which it plans to sell and is in the process of expanding its product line. The Company’s primary product to date is Hemp Biomass, which is sold pre-processed to customers and partners who process the biomass into Hemp Extracts. The Company has cultivated approximately 100,000 kilograms of Hemp Biomass.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:VRTHF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
Next
(0)
•••
CBintel
X
View Profile
View Bullboard History
Post by
CBintel
on Feb 11, 2019 3:46pm
New investigation license
https://web.tmxmoney.com/article.php?newsid=8008961180881640&qm_symbol=VRT:CNX
(1)
•••
Brainboy16
X
View Profile
View Bullboard History
Post by
Brainboy16
on Feb 11, 2019 11:28am
Long way back zu $9 VRT
Hope after Share consolidation we hit fast $2-3 and in the long term, i hope to see the ATH at $9 again. Much hope. I know. But perhaps..... GLTA
Access North American AND Australian listed and Pre-IPO opportunities – here!
posted Dec 27, 2024 9:00am by
Stockhouse Publishing Ltd.
-
|
For the first time on Stockhouse, Canadian investors can access ASX-listed opportunities through our partnership with HotCopper in Australia, opening doors to high-potential investments at the click of a button. Learn more here… ...read more
(22)
•••
longsolo
X
View Profile
View Bullboard History
Comment by
longsolo
on Feb 08, 2019 3:19pm
RE:RE:News should be coming out any day now.
I need to be the optimist as I have little choice left. I am hoping they do the reverse split then come out with the x strain positive news, a long with all the rest of the news.
(1)
•••
Lush223
X
View Profile
View Bullboard History
Comment by
Lush223
on Feb 04, 2019 11:08pm
RE:News should be coming out any day now.
Well here’s a big steaming pant leg load of news for ya; schit gamble on my part! Veritas Pharma to Proceed with Share Consolidation VANCOUVER, British Columbia, Feb.
...more
(22)
•••
longsolo
X
View Profile
View Bullboard History
Post by
longsolo
on Feb 04, 2019 12:04pm
News should be coming out any day now.
Should be some big news coming out any day now. 1. Where the trials are for x strain. 2. Production purchase update. 3. PATENT update. 4. Offer for services for testing products update. 5. Wtf is
...more
(22)
•••
longsolo
X
View Profile
View Bullboard History
Post by
longsolo
on Jan 23, 2019 2:23pm
WTF?
500000 shares traded today. Where the f@^@ is all the news?
(1)
•••
Lush223
X
View Profile
View Bullboard History
Post by
Lush223
on Jan 15, 2019 9:12am
News Release
Veritas Pharma Signs MOU with Santa Marta Gold Holdings for a Medical Cannabis Research Collaboration VANCOUVER, British Columbia, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:
...more
(1)
•••
Lush223
X
View Profile
View Bullboard History
Post by
Lush223
on Jan 09, 2019 9:32pm
VRT what happened!?!?
Hey Luigi, I’m ok with you paying yourself $491,154 up from $140,465 from in 2017 BUT a 10:1 reverse split? Fock sakes!!! Keep being brutal VRT. For what it’s worth I’m sending in my vote. Bye bye
...more
(0)
•••
Canna Chemist
X
View Profile
View Bullboard History
Post by
Canna Chemist
on Jan 03, 2019 10:22am
New management
If you guys read the only new info coming from VRT you notice that they have changed management, except the CEO (who is now getting paid total almost 500k). I wonder why they changed the CFO and COO
...more
(3)
•••
munibags
X
View Profile
View Bullboard History
Post by
munibags
on Dec 25, 2018 7:07pm
All I Ask For Christmas....
When will we see the insider's step up and begin investing their own $$$$ in this VRT? I'm down 80% on this stock and refuse to average down until I see mgt step it up....Also a little
...more
(22)
•••
longsolo
X
View Profile
View Bullboard History
Comment by
longsolo
on Dec 20, 2018 9:51am
RE:RE:RE:RE:RE:RE:VRT a $5 Stock in 2019 ?
Well news is late or missing again. Trial's to start early next month was said Nov 8th. Wheres the news???????
Prev
1
2
3
4
5
6
7
8
9
10
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Learn How this Company is Disrupting Point-of-Care Testing
Why Dozens of Pro Athletes are Paying Attention to this Product
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
A potential breakthrough in spinal cord and optic nerve injury treatment